Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aseel Kashkush

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Discovery|April 6, 2025
Advancing target validation with PROTAC technologyM Leora Spitz, Aseel Kashkush, Raphael I Benhamou
ACS Pharmacology & Translational Science|September 19, 2025
Development of PROTAC-Based Strategies for Cannabinoid Receptor Type 1 (CB<sub>1</sub>R) Degradation in CancerAseel Kashkush, Kisanet Tadesse, Judith Furth-Lavi, et al.
Macromolecular Bioscience|November 22, 2024
PROTAC and Molecular Glue Degraders of the Oncogenic RNA Binding Protein Lin28Aseel Kashkush, Judith Furth-Lavi, Jiri Hodon, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Discovery|April 6, 2025
Advancing target validation with PROTAC technologyM Leora Spitz, Aseel Kashkush, Raphael I Benhamou
ACS Pharmacology & Translational Science|September 19, 2025
Development of PROTAC-Based Strategies for Cannabinoid Receptor Type 1 (CB<sub>1</sub>R) Degradation in CancerAseel Kashkush, Kisanet Tadesse, Judith Furth-Lavi, et al.
Macromolecular Bioscience|November 22, 2024
PROTAC and Molecular Glue Degraders of the Oncogenic RNA Binding Protein Lin28Aseel Kashkush, Judith Furth-Lavi, Jiri Hodon, et al.
Pageof 1